Go back to News
NEWS
GA_P advises Uriach on the minority investment in ICG and the acquisition of French group Laboratories Ineldea
15 of November, 2023
AGómez-Acebo & Pombo has advised Grupo J. Uriach, a Catalan company specialising in the Natural Consumer Healthcare sector, on the entry of the private equity fund ICG in its share capital and on the simultaneous acquisition of the French group Laboratories Ineldea.
With this acquisition, Grupo J. Uriach aims to have a turnover of 450 million euros by 2025, in addition to consolidating its leadership in the Natural Consumer Healthcare business in Europe and strengthening its position in the countries where it already operates, consolidating more powerful local businesses.
The closing of both transactions is subject, among others, to regulatory approvals.
The GA_P team has been led by Daniel Marín, Carolina Posse and Beatriz Dosdá, partner and associates of Corporate, together with Zina Safer, head of the legal department of Grupo J. Uriach. Uriach Group. The transaction has also been advised by Iñigo Igartua, Andrea Díez de Uré and Jesús Urriza, partner and associates of Competition, and Rafael Aguilera and Iñigo Arrieta, partner and associates of Banking.
Read full article
With this acquisition, Grupo J. Uriach aims to have a turnover of 450 million euros by 2025, in addition to consolidating its leadership in the Natural Consumer Healthcare business in Europe and strengthening its position in the countries where it already operates, consolidating more powerful local businesses.
The closing of both transactions is subject, among others, to regulatory approvals.
The GA_P team has been led by Daniel Marín, Carolina Posse and Beatriz Dosdá, partner and associates of Corporate, together with Zina Safer, head of the legal department of Grupo J. Uriach. Uriach Group. The transaction has also been advised by Iñigo Igartua, Andrea Díez de Uré and Jesús Urriza, partner and associates of Competition, and Rafael Aguilera and Iñigo Arrieta, partner and associates of Banking.
Read full article
Tipology
Deal
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
Automoción y Movilidad N.º 25
Resumen de novedades legislativas y jurisprudenciales relativas al sector de la Automoción.
28 Nov, 2024
PUBLICATION
Pharma & Healthcare No. 41
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
26 Nov, 2024
PUBLICATION
Farma & Salud N.º 41
Se recogen las principales novedades legislativas y jurisprudenciales en el sector de Farma & Salud.
21 Nov, 2024
PUBLICATION
Listing Act amendments to the Prospectus Regulation
The reform of the Prospectus Regulation to facilitate access to funding through securities markets, especially by SMEs, is pending publication in the OJEU.
04 Nov, 2024
PUBLICATION
Novo Banco immunity to consumer lawsuits concerning unfair terms in contracts entered into with Banco Espírito Santo
The regulation of bank restructurings is not favourable to consumers.
01 Oct, 2024
PUBLICATION
Due diligence: the risk-based approach and the financial sector
The recent adoption of the Corporate Sustainability Due Diligence Directive will lead to the adoption by large companies of a due diligence system. The basis for its design is an analysis of the risks that business activities may have a negative impact on the environment and human rights. The financial sector has been taking these issues into account for years.
07 Jun, 2024